Metabolic consequences of incorrect insulin administration techniques in aging subjects with diabetes

Acta Diabetologica

Volumn 48, Issue 2, 2011, Pages 121-125

  Gentile, Sandro ^a   Agrusta, Mariano ^b   Guarino, Giuseppina ^a   Carbone, Lucia ^a   Cavallaro, Vincenzo ^b   Carucci, Iarba ^c   Strollo, Felice ^c  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Cardiology Unit   (Italy)

^c INRCA   (Italy)

Author keywords

Aging; Glucose; Insulin; Metabolism; Skin

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN DERIVATIVE; INSULIN GLARGINE;

ADULT; AGE; ARTICLE; CLINICAL EXAMINATION; DIABETES MELLITUS; DRUG ABSORPTION; FEMALE; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INJECTION SITE CONTUSION; INJECTION SITE NODULE; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LIPODYSTROPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SKIN DEFECT; SKIN EXAMINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HUMANS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MEDICATION ERRORS; METABOLIC DISEASES; MIDDLE AGED; SKIN DISEASES; YOUNG ADULT;

EID: 79960243651     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-009-0172-x     Document Type: Article

References (19)

1. A Nicolucci E Ciccarone A Consoli, et al. 2000 Relationship between patient practice-oriented knowledge and metabolic control in intensively treated type 1 diabetic patients: results of the validation of the knowledge and practices diabetes questionnaire Diabetes Nutr Metab 13 276 283 11105970 1:STN:280:DC%2BD3M7islOisw%3D%3D
2. H Gin H Hanaire-Broutin 2005 Reproducibility and variability in the action of injected insulin Diabetes Metab 31 7 13 15803107 10.1016/S1262- 3636(07)70160-X 1:CAS:528:DC%2BD2MXivVOku78%3D (Pubitemid 40327587)
3. B Guerci JP Suavenet 2005 Subcutaneous insulin: pharmacokinetic variability and glycemic variability Diabetes Metab 31 454 457
4. RJ Young MJ Steel BM Frier LJ Duncan 1981 Insulin injection sites in diabetes: a neglected area? BMJ 283 349 6788324 10.1136/bmj.283.6287.349 1:STN:280:DyaL3M3jtlylug%3D%3D (Pubitemid 12250674)
5. K Hambridge 2007 The management of lipodystrophy in diabetes care Br J Nurs 16 520 524 17551441
6. T Richardson D Kerr 2003 Skin-related complications of insulin therapy: epidemiology and emerging management strategies Am J Clin Dermatol 4 661 667 14507228 10.2165/00128071-200304100-00001 (Pubitemid 37411982)
7. L Schiazza C Ocella D Bleidi E Rampini 1990 Insulin lipohypertrophy J Am Acad Dermatol 104 145 149
8. J Fujikura 2005 Insulin-induced lipohypertrophy: report of a case with histopathology Endocrine J 51 623 628 10.1507/endocrj.52.623 (Pubitemid 41609054)
9. ME Wallymahmed P Littler C Clegg, et al. 2004 Nodules of fibrocollagenous scar tissue induced by subcutaneous insulin injections: a cause of poor diabetic control Postgrad Med J 80 950 732 733 15579616 10.1136/pgmj.2004.019547 1:STN:280:DC%2BD2cngs1Ohug%3D%3D (Pubitemid 39627108)
10. X Lopez M Castells A Ricker EF Velazques, et al. 2008 Human insulin analog-induced lipoatrophy Diabetes Care 31 442 444 18162498 10.2337/dc07-1739
11. A Géloën AJ Collet G Guay LJ Bukowiecki 1989 Insulin stimulates in vivo cell proliferation in white adipose tissue Am J Physiol 256 C190 C196 2643334
12. UB Johansson S Amsberg L Hannerz, et al. 2005 Impaired absorption of insulin aspart from lipoypertrophic injecton sites Diabetes Care 28 2025 2027 16043749 10.2337/diacare.28.8.2025 (Pubitemid 41060979)
13. H Gin H Hanaire-Brutin 2005 Reproducibility and variability in the action of injected insulin Diabetes Metab 31 7 13 15803107 10.1016/S1262-3636(07) 70160-X 1:CAS:528:DC%2BD2MXivVOku78%3D (Pubitemid 40327587)
14. Gentile S, Carbone L, Guarino G, De Blasi V et al (2007) Alterazioni di cute e sottocute da somministrazione di insulina e compenso glico-metabolico nel diabetico tipo 2 insulino-trattato. In: Atti XVI congresso nazionale AMD. Pacini, Pisa, pp 246-250
15. The Diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study research group (2005). Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353: 2643-2653
16. I Stratton AL Adler HA Neil, et al. 2000 Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ 21 405 412 10.1136/bmj.321.7258.405 (Pubitemid 30609442)
17. P Gaede P Vedel N Larsen, et al. 2003 Multifactorial intervention and cardiovasculardisease in patients with type 2 diabetes N Engl J Med 348 383 393 12556541 10.1056/NEJMoa021778 (Pubitemid 36159355)
18. L Rydén E Standl M Bartnik G Van den Berghe, et al. 2007 Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The task force on diabetes and cardiovascular diseases of the European society of cardiology (ESC) and of the European association for the study of diabetes (EASD) Eur Heart J 28 88 136 17220161 10.1093/eurheartj/ehm124 (Pubitemid 47355991)
19. Italian Standards for Diabetes Mellitus (2007) In: Bonomo M et al (eds) Infomedica, Turin, pp 43-45